Phase 1 study evaluating the safety, tolerability, pharmacokinetics (PK), and efficacy of GEC255, a novel KRAS(G12C) inhibitor, in advanced solid tumorsYan Zhang,Lin Zhou,Youling Gong,Meijuan Huang,Min Tang,Yongmei Liu, Min Yu,Weigang Xiu, Xinjun Liang, Xinyu Liu,Xin-Yuan Fu,You LuJOURNAL OF CLINICAL ONCOLOGY（2023）引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
